Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia

Published:2013-02-01 Issue:1 Volume:161 Page:95-103
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kako Shinichi¹,Kanamori Heiwa²,Kobayashi Naoki³,Shigematsu Akio⁴,Nannya Yasuhito⁵,Nakamae Mika⁶,Shigeno Kazuyuki⁷,Suzukawa Kazumi⁸,Takeuchi Masahiro⁹,Tsuzuki Motohiro¹⁰,Usuki Kensuke¹¹,Hatanaka Kazuo¹²,Ogawa Kazuei¹³,Mitani Kinuko¹⁴,Nawa Yuichiro¹⁵,Hatta Yoshihiro¹⁶,Mizuno Ishikazu¹⁷,Kanda Yoshinobu¹

Affiliation:

1. Division of Haematology; Saitama Medical Centre; Jichi Medical University; Saitama; Japan

2. Department of Haematology; Kanagawa Cancer Centre; Kanagawa; Japan

3. Department of Haematology; Sapporo Hokuyu Hospital; Hokkaido; Japan

4. Department of Haematology and Oncology; Hokkaido University Graduate School of Medicine; Hokkaido; Japan

5. Department of Haematology and Oncology; Graduate School of Medicine; University of Tokyo; Tokyo; Japan

6. Haematology; Graduate School of Medicine; Osaka City University; Osaka; Japan

7. Department of Internal Medicine III; Hamamatsu University School of Medicine; Shizuoka; Japan

8. Department of Clinical and Experimental Haematology; Institute of Clinical Medicine; University of Tsukuba; Ibaraki; Japan

9. Department of Haematology; Chiba University Hospital; Chiba; Japan

10. Department of Haematology; School of Medicine; Fujita Health University; Aichi; Japan

11. Division of Haematology; NTT Kanto Medical Centre; Tokyo; Japan

12. Department of Haematology; Rinku General Medical Centre; Osaka; Japan

13. Department of Cardiology and Haematology; Fukushima Medical University; Fukushima; Japan

14. Department of Haematology and Oncology; Dokkyo Medical University School of Medicine; Tochigi; Japan

15. Division of Haematology; Ehime Prefectural Central Hospital; Ehime; Japan

16. Department of Haematology and Rheumatology; Nihon University School of Medicine; Tokyo; Japan

17. Haematology Division; Department of Medicine; Hyogo Cancer Centre; Hyogo; Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12225/fullpdf

Reference23 articles.

1. Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia;Amadori;Journal of Clinical Oncology,1991

2. GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia;Camera;Haematologica,2004

3. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison;Cornelissen;Blood,2009

4. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007

5. Salvage therapy for refractory or relapsed acute lymphocytic leukemia;Garcia-Manero;Hematology/oncology Clinics of North America,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia;Cancer Medicine;2023-11-13

2. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission;Transplantation and Cellular Therapy;2022-06

3. Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation;International Journal of Hematology;2022-05-09

4. Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission;Transplantation and Cellular Therapy;2021-12

5. A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation;International Journal of Hematology;2021-09-06